TransMedics (TMDX) Short-term Investments (2019 - 2022)

TransMedics' Short-term Investments history runs 4 years deep, the most recent figure standing at $27.7 million for Q2 2022.

• On a quarterly basis, Short-term Investments fell 68.14% year-over-year to $27.7 million in Q2 2022; TTM through Jun 2022 was $27.7 million, a 68.14% decrease from a year earlier, with the FY2021 full-year figure at $66.9 million, down 33.83% from the prior year.
• Short-term Investments eased to $27.7 million in Q2 2022 per TMDX's latest filing, from $54.1 million in the prior quarter.
• Across five years, Short-term Investments topped out at $111.3 million in Q3 2020 and bottomed at $27.7 million in Q2 2022.
• The 4-year median for Short-term Investments is $67.4 million (2019), against an average of $70.4 million.
• Across the five-year window, Short-term Investments jumped 91.12% in 2021 and plunged 68.14% in 2022, its largest moves.
• Year by year, Short-term Investments stood at $60.6 million in 2019, then soared by 66.78% to $101.1 million in 2020, then plunged by 33.83% to $66.9 million in 2021, then tumbled by 58.58% to $27.7 million in 2022.
• Per Business Quant, the three latest TMDX Short-term Investments figures stand at $27.7 million (Q2 2022), $54.1 million (Q1 2022), and $66.9 million (Q4 2021).